News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,388 Results
Type
Article (43823)
Company Profile (318)
Press Release (698233)
Multimedia
Podcasts (116)
Webinars (19)
Section
Business (210993)
Career Advice (2109)
Deals (36759)
Drug Delivery (124)
Drug Development (83421)
Employer Resources (176)
FDA (16831)
Job Trends (15503)
News (357377)
Policy (34132)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2616)
Accelerated approval (34)
Adcomms (26)
Allergies (150)
Alliances (51584)
ALS (174)
Alzheimer's disease (1700)
Antibody-drug conjugate (ADC) (327)
Approvals (17096)
Artificial intelligence (543)
Autoimmune disease (162)
Automation (42)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (21)
Biosimilars (198)
Biotechnology (188)
Bladder cancer (160)
Brain cancer (61)
Breast cancer (655)
Cancer (4935)
Cardiovascular disease (421)
Career advice (1788)
Career pathing (37)
CAR-T (287)
CDC (49)
Celiac Disease (2)
Cell therapy (763)
Cervical cancer (36)
Clinical research (71211)
Collaboration (1776)
Company closure (4)
Compensation (1181)
Complete response letters (65)
COVID-19 (2788)
CRISPR (99)
C-suite (890)
Cystic fibrosis (148)
Data (6337)
Decentralized trials (2)
Denatured (36)
Depression (138)
Diabetes (510)
Diagnostics (6797)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (263)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (235)
Earnings (91992)
Editorial (61)
Employer branding (21)
Employer resources (155)
Events (120363)
Executive appointments (1008)
FDA (20015)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1498)
Gene editing (206)
Generative AI (46)
Gene therapy (617)
GLP-1 (1015)
Government (4810)
Grass and pollen (7)
Guidances (385)
Healthcare (19066)
HIV (62)
Huntington's disease (46)
IgA nephropathy (86)
Immunology and inflammation (266)
Immuno-oncology (61)
Indications (119)
Infectious disease (3065)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (259)
Interviews (327)
IPO (16921)
IRA (57)
Job creations (4070)
Job search strategy (1498)
JPM (64)
Kidney cancer (16)
Labor market (86)
Layoffs (576)
Leadership (34)
Legal (8425)
Liver cancer (92)
Longevity (16)
Lung cancer (665)
Lymphoma (385)
Machine learning (43)
Management (60)
Manufacturing (837)
MASH (170)
Medical device (13865)
Medtech (13921)
Mergers & acquisitions (20914)
Metabolic disorders (1311)
Multiple sclerosis (164)
NASH (17)
Neurodegenerative disease (328)
Neuropsychiatric disorders (92)
Neuroscience (2974)
Neurotech (1)
NextGen: Class of 2026 (6644)
Non-profit (4563)
Now hiring (68)
Obesity (620)
Opinion (289)
Ovarian cancer (168)
Pain (217)
Pancreatic cancer (232)
Parkinson's disease (286)
Partnered (34)
Patents (515)
Patient recruitment (502)
Peanut (60)
People (60952)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22104)
Phase 2 (31308)
Phase 3 (23460)
Pipeline (5491)
Policy (303)
Postmarket research (2655)
Preclinical (9390)
Press Release (68)
Prostate cancer (242)
Psychedelics (50)
Radiopharmaceuticals (290)
Rare diseases (880)
Real estate (6306)
Recruiting (72)
Regulatory (25453)
Reports (53)
Research institute (2441)
Resumes & cover letters (361)
Rett syndrome (27)
RNA editing (17)
RSV (81)
Schizophrenia (156)
Series A (246)
Series B (194)
Service/supplier (11)
Sickle cell disease (100)
Special edition (25)
Spinal muscular atrophy (160)
Sponsored (43)
Startups (3766)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (96)
The Weekly (78)
Vaccines (1043)
Venture capital (91)
Weight loss (405)
Women's health (94)
Worklife (18)
Date
Last 7 days (576)
Last 30 days (2255)
Last 365 days (30212)
2026 (4046)
2025 (30680)
2024 (35767)
2023 (40629)
2022 (51798)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35771)
2017 (33136)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29730)
2011 (30487)
2010 (28500)
Location
Africa (800)
Alabama (84)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (42172)
Australia (6753)
California (11465)
Canada (3343)
China (1143)
Colorado (483)
Connecticut (486)
Delaware (345)
Europe (90452)
Florida (1717)
Georgia (361)
Hawaii (3)
Idaho (61)
Illinois (889)
India (72)
Indiana (537)
Iowa (22)
Japan (448)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1404)
Massachusetts (8249)
Michigan (330)
Minnesota (635)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3046)
New Mexico (29)
New York (3026)
North Carolina (1492)
North Dakota (8)
Northern California (5600)
Ohio (339)
Oklahoma (22)
Oregon (46)
Pennsylvania (2322)
Puerto Rico (24)
Rhode Island (48)
South America (1175)
South Carolina (68)
South Dakota (1)
Southern California (4468)
Tennessee (177)
Texas (1770)
United States (40761)
Utah (343)
Vermont (1)
Virginia (280)
Washington D.C. (81)
Washington State (937)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
742,388 Results for "inmed pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update
Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer’s disease pathology Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026
September 23, 2025
·
12 min read
Press Releases
InMed to Present INM-901 Data at Alzheimer’s Association International Conference (AAIC) 2025
Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activity
July 28, 2025
·
5 min read
Press Releases
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
February 12, 2026
·
12 min read
Press Releases
InMed Provides Update on BayMedica Commercial Business
December 12, 2025
·
5 min read
Press Releases
InMed Announces Results of 2025 Annual General and Special Meeting
December 18, 2025
·
4 min read
Press Releases
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
October 16, 2025
·
4 min read
Press Releases
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It’s Board of Directors
October 9, 2025
·
4 min read
Press Releases
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901
November 18, 2025
·
1 min read
Press Releases
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
November 6, 2025
·
10 min read
Press Releases
InMed’s INM-901 Significantly Reduces Neuroinflammation in Alzheimer’s Disease Ex Vivo Study
June 24, 2025
·
6 min read
1 of 74,239
Next
